Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic andā¦ read more
Healthcare
Biotechnology
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$240.48
Price-0.34%
-$0.83
1Y
Price
Market Cap
$15.106b
Large
Price/Earnings 3y Avg5y Avg
9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+34.6%
EBITDA Margin+16.0%
Net Profit Margin+32.9%
Free Cash Flow Margin+34.6%
EBITDA Margin+16.0%
Net Profit Margin+32.9%
Free Cash Flow MarginRevenue
$4.601b
+7.8%
1y CAGR+6.3%
3y CAGR+5.9%
5y CAGREarnings
$940.763m
+364.2%
1y CAGR+78.5%
3y CAGR+130.2%
5y CAGREPS
$14.63
+350.5%
1y CAGR+74.9%
3y CAGR+123.8%
5y CAGRBook Value
$4.802b
$11.081b
Assets$6.279b
Liabilities$4.409b
DebtDebt to Assets
39.8%
3x
Debt to EBITDAFree Cash Flow
$1.542b
+34.6%
1y CAGR+15.3%
3y CAGR+21.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company